Psychological adjustment to familial-genetic risk assessment for ovarian cancer: Predictors of nonadherence to surveillance recommendations

Gynecologic Oncology

Volumn 84, Issue 1, 2002, Pages 72-80

  Ritvo, P ^a,b,c   Irvine, J ^a,c   Robinson, G ^a   Brown, L ^a,c   Murphy, K J ^a   Matthew, A ^a   Rosen, B ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b CANCER CARE ONTARIO   (Canada)

^c YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADJUSTMENT; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; COPING BEHAVIOR; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; GENETIC RISK; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RISK ASSESSMENT; SCORING SYSTEM; SELF REPORT; SOCIAL SUPPORT;

EID: 0036142669     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6461     Document Type: Article

References (47)

1. The psychological costs of screening for cancer
2. Increased absenteeism from work after detecting and labelling of hypertensive patients
3. Hypertension labelling and sense of well-being
4. DNA screening for breast/ovarian cancer susceptibility based on linked markers
5. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
6. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
7. Psychological impact of genetic testing
8. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes
9. Psychological responses to BRCA1 mutation testing: Preliminary findings
10. Psychological impact of screening for familial ovarian cancer: Reactions to initial assessment
11. A longitudinal study of psychological adjustment to familial genetic risk assessment in ovarian cancer
12. Psychological adjustment to familial genetic risk assessment in ovarian cancer: A comparison of two samples
13. Familial ovarian cancer
14. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
15. Risks of cancer in BRCA1 mutation carriers
16. Identification of the breast cancer susceptibility gene BRCA2
17. BRCA2 mutations in primary breast and ovarian cancers
18. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families
19. Mismatch repair, genetic stability, and cancer
20. Lifetime risk of different cancers in hereditary non-polyposis cotorectal cancer (HNPCC) syndrome
21. Familial ovarian cancer
22. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer
23. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals
24. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
25. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families
26. The CES-D scale: A self-report depression scale for research in the general population
27. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test
28. How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer
29. The MOS social support survey
30. Development of the Texas inventory of grief
31. Assessing coping strategies: A theoretically based approach
32. A randomized trial of breast cancer risk counseling: The impact on self-reported mammography use
33. Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer
34. Genetic risk and behavioural change
35. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing
36. Psychological aspects of cancer screening in high-risk populations
37. The impact of a brief coping skills intervention on adherence to breast self-examination among first-degree relatives of newly diagnosed breast cancer patients
38. Patient adherence to family practitioners' recommendations for breast cancer screening: A historical cohort study
39. Methodology for targeting physicians for interventions to improve breast cancer screening
40. Do follow-up recommendations for abnormal Papinicolanu smears influence patient adherence?
41. Effectiveness of a telephone outcall intervention to promote screening mammography among low-income women
42. Breast screening behaviour and interactions with health care providers among lower income women
43. Using physician correspondence and postcard reminders to promote mammography use
44. Utilization of ovarian cancer screening by women at increased risk
45. Attitudes about genetic testing for breast cancer susceptibility